Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding significant costs incurred during the launch of Claybourne pre-rolled joints and the Storz & Bickel vaporizer devices, which adversely affected the company's gross margins and financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures and misrepresented the health of its gross margins while downplaying related issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and misrepresented the health of its gross margins while downplaying existing issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][2]. Allegations - The complaint alleges that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints during its product launch in Canada [1]. - It is claimed that these costs, along with indirect costs from Storz & Bickel vaporizer devices, negatively affected the company's gross margins and overall financial results [1]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying existing issues [1]. - As a result, the public statements made by the defendants are considered materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from May 30, 2024, to February 6, 2025, and shareholders are encouraged to register by June 3, 2025, to participate [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies engage in responsible business practices and good corporate citizenship [3].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the launch of Claybourne pre-rolled joints and the Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying related issues, leading to materially false and misleading public statements [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action lawsuit has been filed against Canopy Growth Corporation for allegedly misleading investors regarding its cost reduction measures and financial performance during a specified period [1][2]. Allegations - The lawsuit claims that Canopy Growth Corporation failed to disclose significant costs associated with the production of Claybourne pre-rolled joints and indirect costs related to Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures while downplaying issues related to its gross margins [2]. Financial Impact - On February 7, 2025, Canopy announced disappointing financial results attributed to the costs from the Claybourne product launch and increased indirect costs, leading to a 27.24% drop in share price, closing at $2.02 [3]. Class Action Participation - Shareholders may be eligible to participate in the class action against Canopy Growth Corporation, with a deadline for lead plaintiff applications set for June 3, 2025 [4]. Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Canopy Growth Corporation ("Canopy Growth Corporation" or the "Company") (NASDAQ: CGC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Canopy Growth Corporation investors who were adversely affected by alleged securities fraud between May 30, 2024 and February 6, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zl ...

Industry Overview - The U.S. cannabis industry is projected to reach approximately $45 billion by 2025 and over $75 billion by 2030, driven by federal reform discussions and expanding legalization [1][2] - Canadian cannabis companies are strategically positioning themselves for growth in the U.S. market through acquisitions and partnerships [1][2] Company Highlights Tilray Brands Inc. - Tilray operates in Canada, Europe, and the U.S., focusing on wellness and beverage sectors, distributing THC-infused beverages in over 10 U.S. states [3][5] - In Q3 fiscal 2025, Tilray reported revenue of $185.8 million, with a gross profit of $52 million, marking a 5% increase in gross margin to 28% [7][8] - Despite a net loss of $793.5 million primarily due to non-cash impairment charges, Tilray reduced its overall debt by $76 million, indicating a commitment to financial sustainability [8] Canopy Growth Corporation - Canopy Growth, a prominent cannabis producer in Canada, has shifted its U.S. strategy through Canopy USA, allowing it to engage with American operators while adhering to federal laws [9][11] - The company reported Q3 fiscal 2025 revenue of $74.8 million, a 5% decline year-over-year, but an 8% increase when excluding divested businesses [12][13] - Canopy's medical cannabis business in Canada remains strong, and the company prepaid a $100 million loan to improve cash flow and reduce interest costs [13] Village Farms International Inc. - Village Farms transitioned from greenhouse vegetable growing to cannabis production through its Pure Sunfarms subsidiary, focusing on wellness-based expansion in the U.S. [14][16] - In Q1 2025, Village Farms reported consolidated revenue of $77.1 million, slightly down from $78.1 million the previous year, but its Canadian cannabis segment achieved a net income of $3 million, a 258% increase [17][18] - The company plans to privatize part of its produce business to concentrate resources on its cannabis operations, which is expected to unlock more value [18] Investment Outlook - Canadian cannabis companies like Tilray, Canopy, and Village Farms are actively restructuring operations and improving balance sheets to capture growth in the U.S. market [19][20] - Each company has shown improvements in key financial metrics, with Tilray leading in beverages, Canopy leveraging brand strength, and Village Farms excelling in operational efficiency [20]

NEW YORK, May 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Canopy Growth Corporation ("Canopy Growth Corporation" or the "Company") (NASDAQ: CGC) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Canopy Growth Corporation investors who were adversely affected by alleged securities fraud between May 30, 2024 and February 6, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/ ...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Canopy Growth Corporation (NASDAQ: CGC). Shareholders who purchased shares of CGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/canopy-growth-corporation-loss-submission-form-2/?id=147741&from=3 CLASS PE ...